KRAS and neoplasm: Another insight for further research concerns the possibility of a pro-thombogenic molecular landscape, as suggested by recent work affirming that KRAS mutation and STK-11 are associated significantly with ATEs, independently of tumor type, even if the mechanism for this association has not been clarified [28].